Abstract
Lung transplant recipients have a high incidence of pulmonary aspergillosis which is associated with high morbidity and mortality despite antifungal prophylaxis and treatment. Early diagnosis is associated with improved survival. Given the poor sensitivity of conventional mycological culture in respiratory samples, we determine the utility of novel Aspergillus antigen and PCR based diagnostic tests in a cohort of lung transplant recipients.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
